Lobbying Disclosure: Pfizer Inc. (Q1 2000)
June 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This report tracks the financial relationship between a major pharmaceutical company and its hired lobbyists, identifying which specific state legislation the company sought to influence during the reporting period.
Potentially affected actors named in the source documents. Mention is not a position.
Pfizer Inc.
The company is the entity paying for lobbying services to influence state legislation.
Nielsen Merksamer Parrinello Mueller & Naylor LLP
The firm is the recipient of lobbying fees and is responsible for reporting these activities.
Last recorded activity June 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- Pfizer Inc. paid $436.50 to Nielsen Merksamer Parrinello Mueller & Naylor LLP for lobbying services.
- The reporting period for these payments is January 1, 2000, through March 31, 2000.
- The payment amount includes fees for services rendered during the 4th quarter of 1999.
- The lobbying activity focused on two specific pieces of legislation: AB 15 and SB 1254.
Why It Matters
This report tracks the financial relationship between a major pharmaceutical company and its hired lobbyists, identifying which specific state legislation the company sought to influence during the reporting period.
Frequently Asked Questions
What does this document show?
Does the $436.50 cover only the first quarter of 2000?
News Coverage
Lobbying Activity
NIELSEN MERKSAMER PARRINELLO MUELLER & NAYLOR LLP
on behalf of PFIZER INC.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Delayed Payment Reporting
The lobbying payment for Q1 2000 includes outstanding balances from Q4 1999, indicating a lag in billing or payment cycles.
Connected Entities
Sources
www.sos.ca.gov
Analysis Score
0–100- Significance20How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools